Patent details
EP3454850 Title: COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY WITH THROMBOXANE-A2 RECEPTOR ANTAGONISTS
Basic Information
- Publication number:
- EP3454850
- PCT Application Number:
- US2017032151
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP177968377
- PCT Publication Number:
- WO2017197107
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY WITH THROMBOXANE-A2 RECEPTOR ANTAGONISTS
- French Title of Invention:
- COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE DYSTROPHIE MUSCULAIRE À L'AIDE D'ANTAGONISTES DU RÉCEPTEUR DU THROMBOXANE A2
- German Title of Invention:
- ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON MUSKELDYSTROPHIE MIT THROMBOXAN-A2-REZEPTOR-ANTAGONISTEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 20/07/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 26/07/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 21/06/2023
- Unitary Effect Registration Date:
- 26/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 11/05/2017
- Grant date:
- 21/06/2023
- EP Publication Date:
- 20/03/2019
- PCT Publication Date:
- 16/11/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/06/2023
- EP B1 Publication Date:
- 21/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 11/05/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/06/2023
- Name:
- Cumberland Pharmaceuticals Inc.
- Address:
- 2525 West End Avenue Suite 950, Nashville, TN 37203, United States (US)
- Name:
- Vanderbilt University
- Address:
- 305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37240, United States (US)
Inventor
1
- Name:
- WEST, James
- Address:
- United States (US)
2
- Name:
- CARRIER, Erica
- Address:
- United States (US)
3
- Name:
- MACIAS-PEREZ, Ines
- Address:
- United States (US)
4
- Name:
- LEO, Pavliv
- Address:
- United States (US)
Priority
- Priority Number:
- 201662334748 P
- Priority Date:
- 11/05/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/422; A61K 9/08; A61K 9/20; A61P 21/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202325
- Publication date:
- 21/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202334
- Publication date:
- 23/08/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202335
- Publication date:
- 30/08/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|